skip to Main Content

Welcome to Responsum Health

Responsum Health is harnessing the promise of the Internet to better inform and engage patients with chronic conditions. Join us!

Get In Touch

Email: info@responsumhealth.com
Phone: +1 (949) 264 2277
Headquarters Office: Washington, DC
Operations Office: Irvine, CA

Our Location

Do you qualify?

Find out if you are eligible for this clinical trial for idiopathic pulmonary fibrosis

Fill out the pre-screening form
You may qualify to participate if:
You are 40 years of age or older and can come to a study center for routine visits
You have been diagnosed within five years
You haven't been diagnosed with an immunosuppressive condition, such as HIV
You have not yet had a lung transplant

What will study participants receive?

  • Study medication
  • Study-related medical care
  • Reimbursement for study-related expenses

What is the online qualification process?

Find out if you qualify

You must complete the pre-screening form to see if you qualify for the ISABELA1 clinical trial.* Additional information on the study can be found on Responsum Health, as well as on the ISABELA studies website.

Complete a phone screening

If you pass the pre-screening form, you will be contacted by our patient liaison with more details on the clinical trial and qualifications. The patient liaison will answer any questions you may have.

Get referred to a study center

Once you’ve passed all of the eligibility criteria and agreed to be a study participant, you will be referred to a study center for the clinical trial. This is where you must go to complete the final step of the qualification process.

Have an on-site screening visit

At the study center, you will work with the study coordinator to ensure all of the criteria is accurate. You will also have a physical exam to make sure that this clinical trial is a good fit for you and your overall health.

*Please note that if you prequalify online, which is determined by passing the pre-screening form, this does not guarantee you will be enrolled in the clinical trial.

Back To Top